How are you feeling today? Keep up to date on news and stories related to healthcare here!
Transaction expected to close in the coming days SOMERSET, N.J. & COPENHAGEN, Denmark — (BUSINESS WIRE) — Catalent, Inc. (“Catalent,” NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings A/S (“Novo
Ad hoc announcement pursuant to Art. 53 LR Newron will receive up to a maximum of €117 million from an upfront payment, development milestones and commercialization milestones, and up to double-digit tiered royalties on net sales Evenamide is a unique modulator of
Prudential Group Insurance expands suite of resources and services for beneficiaries to help navigate the emotional and practical challenges that come with the loss of a loved one. NEWARK, N.J. — (BUSINESS WIRE) — The loss of a loved one is a
XTORO is a new chemical entity that is FDA approved for the treatment of acute otitis externa, commonly known as “swimmer’s ear,” caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus LONG BEACH TOWNSHIP, N.J. — (BUSINESS WIRE) — Fonseca Biosciences
MORRISTOWN, N.J. — (BUSINESS WIRE) — Majesco, a global leader in cloud insurance software solutions, Tuesday announced the release of its latest Thought Leadership report, 8 Trends Shaping the Future of Insurance in 2025, an annual report highlighting trends for the next
SWEDESBORO, N.J. — (BUSINESS WIRE) — #BlueRabbit — Wedgewood Equine, a dedicated division of Wedgewood, the nation’s largest provider of compounded veterinary medications, is excited to unveil Blue Rabbit for equine veterinarians at this year’s American Association of Equine Practitioners (AAEP) 70th
OXFORD, England & SPRINGFIELD, N.J. — (BUSINESS WIRE) — Orbit Discovery, a leading provider of peptide discovery services, and Evergreen Theragnostics, a radiopharmaceutical company at the forefront of precision medicine, on Tuesday announced an extension to their research collaboration to find novel
HAYWARD, Calif. — (BUSINESS WIRE) — #Biotech — Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, recently announced that Michael A. Klobuchar has been appointed Chief Operating Officer. He joins Eikon from
RAHWAY, N.J. — (BUSINESS WIRE) — Merck (NYSE: MRK), known as MSD outside of the United States and Canada, recently announced that Dr. Eliav Barr, senior vice president, head of global clinical development and chief medical officer, Merck Research Laboratories, is scheduled